Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets identify genetic cause of fatal condition in Thoroughbreds
EFIH is an invariably fatal condition that causes involuntary contraction of muscles and seizures in Thoroughbred foals.
Study of affected foals reveals a mutation in the RAPGEF5 gene.

A genetic cause of equine familial isolated hypoparathyroidism (EFIH) in Thoroughbreds has been identified by researchers at the UC Davis School of Veterinary Medicine.

Researchers say their finding, reported in PloS Genetics, marks the first genetic variant for hypoparathyroidism identified in any domestic animal species. It is also the first widely available genetic test for Thoroughbreds.

“For Thoroughbred owners and breeders, the loss of a foal has tremendous economic and emotional impacts,” says first author Victor Rivas. “It is important to promote safe and strategic breeding habits by actively breeding horses genetically screened not only for EFIH but for other diseases that may impact quality of life.”

EFIH is is an invariably fatal condition that causes involuntary contraction of muscles and seizures in Thoroughbred foals. Foals with the disease typically have low levels of parathyroid - a hormone that controls calcium levels - and often die or are euthanised owing to poor prognosis.

In the study, researchers identified an autosomal recessive mode of inheritance and performed whole-genome sequencing of two affected foals. They found that a mutation in the rap guanine nucleotide exchange factor 5 (RAPGEF5) gene was present in two copies in both foals.

The team further analysed the variant and demonstrated loss-of-function of the RAPGEF5 protein leading to aberrant development. Their study concludes that RAPGEF5 could play a key role in the derivation of the parathyroid gland during development.

“The next steps are to assess the allele frequency in a large population of randomly selected Thoroughbreds,” explained study lead Dr Carrie Finno. “Additionally, we have discussed collaborating with Dr Nathan Slovis at Hagyard Equine Medical Institute in Kentucky to test for the variant in cases of ‘sudden death’ in Thoroughbred foals.”

Become a member or log in to add this story to your CPD history

MSD Animal Health announces three new research bursaries

News Story 1
 MSD Animal Health has announced three new research bursaries for veterinary surgeons in the areas of swine, poultry and aquaculture. The bursaries, worth up to £4,000, add to MSD's existing bursaries in ruminant and companion animal research.

Projects are expected to be completed within one to two years, and the proposals will be judged by university academics to ensure that assessment remains independent. Full project design and application guidelines, including the specific disease/subject areas, can be found on MSD Animal Health's website

Click here for more...
News Shorts
VMD and VPS announce joint open information day

The Veterinary Medicines Directorate (VMD) and the Veterinary Products Committee (VPC) have announced a joint open information day covering topics such as veterinary medicines regulations, antimicrobial resistance, scientific advice and novel therapies.

Taking place on Wednesday 18 November, the virtual event will take the form of a series of pre-recorded webinars and a 'Slido' Q&A session. Links to the webinars and full instructions on how to use Slido will be available on gov.uk on 18 November. To join the mailing list for the event, email director.support@vmd.gov.uk